Pharma Foods International (2929) · RiskMaterialised
Losses arising from currency fluctuations
First written in FY2016-Q3. 10 of 22 entries say "Mitigated", first in FY2017-Q2. Latest entry: FY2025-H1.
22entries
10years
0from disclosures
How it moved
Same theme, other companies
Impact of exchange-rate fluctuations and foreign-currency-denominated transactions on financial resultsA theme 476 companies write about · 414 as a headwind · 20 as a tailwind
Pharma Foods International moved to the "Worse" side of this theme in 2025, 7 years after the typical company in this theme (2018).
The whole theme swung hardest in 2025: 71 of 159 companies on the "Worse" side.
23 other companies' latest entry also says "Materialised".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 195 companies compared. The sentences above are computed from all 195.Comparing 200 of the theme's 490 threads.Full recordFilings, disclosures and news, newest first
- FY2025-H1MaterialisedAnnual report
「Foreign exchange loss 5」
The company recorded ¥5 million in foreign exchange losses in the interim consolidated accounting period under review, changing from the recognition of foreign exchange gains in the previous fiscal year to the occurrence of foreign exchange losses. - FY2024MitigatedAnnual report
「Foreign exchange gain 4」
The company recorded ¥4 million in foreign exchange gains in the fiscal year under review, and no foreign exchange losses were reported. - FY2024-Q3MitigatedAnnual report
「Foreign exchange gain ¥8 million」
In the nine months ended ..., the company recorded ¥8 million in foreign exchange gains, compared with ¥3 million in foreign exchange losses in the same period of the previous year, indicating that the occurrence of foreign exchange losses has eased. - FY2024-Q2MitigatedAnnual report
「Foreign exchange gain 4」
In the six months ended ..., the company recorded ¥4 million in foreign exchange gains, and no foreign exchange losses were reported. - FY2023MitigatedAnnual report
「Foreign exchange gain ¥8 million」
In the fiscal year under review, the company recorded ¥8 million in foreign exchange gains rather than foreign exchange losses, indicating that the occurrence of foreign exchange losses has eased. - FY2021MitigatedAnnual report
「Foreign-exchange gain 16」
During the current consolidated fiscal year, the Company recorded a foreign-exchange gain of ¥16 million rather than a foreign-exchange loss, easing the foreign-exchange loss position. - FY2021-Q3MitigatedAnnual report
「Foreign-exchange gain 22,861」
During the first nine months of the current consolidated fiscal year, the Company recorded a foreign-exchange gain of ¥22.861 million rather than a foreign-exchange loss, easing the foreign-exchange loss position. - FY2021-Q1MitigatedAnnual report
「Foreign-exchange gain 4,608」
The Company recorded a foreign-exchange gain of ¥4.608 million during the first three months of the current consolidated fiscal year, easing the foreign-exchange loss position through the previous fiscal year. - FY2020-Q3MaterialisedAnnual report
「Foreign-exchange loss 4,539」
Following the foreign-exchange loss in the previous quarter, the Company also recorded a foreign-exchange loss of ¥4.539 million during the first nine months of the current consolidated fiscal year. - FY2020-Q2MitigatedAnnual report
「Foreign-exchange gain 845」
A change from the ¥2.425 million foreign-exchange loss in the same period of the previous year, with the Company recording a foreign-exchange gain of ¥845 thousand during the first six months of the current consolidated fiscal year. - FY2020-Q1MitigatedAnnual report
「Foreign-exchange gain 2,440」
The Company recorded a foreign-exchange gain of ¥2.440 million during the first three months of the current consolidated fiscal year, easing the loss position from the ¥12.152 million foreign-exchange loss in the previous consolidated fiscal year. - FY2019MaterialisedAnnual report
「Foreign-exchange loss 12,152」
The Company recorded a foreign-exchange loss of ¥12.152 million during the current consolidated fiscal year, changing from foreign-exchange gains through the previous quarter to a foreign-exchange loss. - FY2019-Q3MaterialisedAnnual report
「Foreign-exchange loss 3,798」
A change from the previously reported foreign-exchange gains, with a foreign-exchange loss of ¥3.798 million actually incurred during the first nine months of the current consolidated fiscal year. - FY2019-Q2MaterialisedAnnual report
「Foreign-exchange loss 2,425」
A change from the previously reported foreign-exchange gains, with a foreign-exchange loss of ¥2.425 million actually incurred during the first six months of the current consolidated fiscal year. - FY2019-Q1RestatedAnnual report
「Foreign-exchange gain 1,377」
The Company also recorded a foreign-exchange gain rather than a foreign-exchange loss for the first three months of the current consolidated fiscal year, and no loss arising from exchange-rate movements was reported. - FY2018-Q3RestatedAnnual report
「Foreign-exchange gain 4,098」
The Company also recorded a foreign-exchange gain for the first nine months of the current consolidated fiscal year, and no foreign-exchange loss was reported. - FY2018-Q2RestatedAnnual report
「Foreign-exchange gain ¥4.210 million」
The Company also recorded a foreign-exchange gain rather than a foreign-exchange loss for the first six months of the current consolidated fiscal year, and no loss arising from exchange-rate movements was reported. - FY2018-Q1RestatedAnnual report
「Foreign-exchange gain ¥4.850 million」
The Company also recorded a foreign-exchange gain rather than a foreign-exchange loss for the cumulative period, and no foreign-exchange loss was reported. - FY2017-Q3RestatedAnnual report
「Foreign Exchange Gains」
The Company also recorded a foreign-exchange gain of ¥3.862 million for the cumulative period, rather than a foreign-exchange loss, and no foreign-exchange loss was reported again. - FY2017-Q2MitigatedAnnual report
「Foreign Exchange Gains」
In non-operating income and expenses for the cumulative period, the Company recorded a foreign-exchange gain of ¥4.654 million rather than a foreign-exchange loss, marking a change from the foreign-exchange losses reported through the previous quarter. - FY2017-Q1RestatedAnnual report
「As a result of recording foreign-exchange losses of ¥1.818 million, ordinary loss was ¥425 million and net loss attributable to owners of the parent was ¥424 million.」
The Company disclosed that foreign-exchange losses were also incurred during the current quarter. - FY2016-Q3First statedAnnual report
「As a result of recording ¥50 million in subsidy income from the drug-discovery business and other operations and ¥11 million in foreign-exchange losses, ordinary loss was ¥277 million and net loss attributable to owners of the parent was ¥275 million.」
The Company recorded ¥11 million in foreign-exchange losses, with the impact of exchange-rate movements reflected in its results.